| INTRODUC TI ON
Mycoplasma pneumoniae accounts for up to 10%-30% of the cases of community-acquired pneumonia (CAP). [1] [2] [3] [4] [5] Unfortunately, conventional microbiological diagnosis by isolating and culturing the organism is complex because its culture is slow and requires specific media. 6 Molecular biology techniques are promising, but a positive result with these techniques does not always indicate a current infection. 7, 8 To date, serological testing is still the main tool for diagnosing M. pneumoniae in many clinical laboratories, even though for an accurate interpretation a number of factors need to be taken into account. M. pneumoniae is a highly prevalent pathogen, and therefore, IgG antibodies are frequently found in the healthy population. 9 Moreover, adults may never develop a measurable IgM response, presumably because of reinfections. 10 Therefore, for the diagnosis of a current infection, both acute and convalescent serum samples need to be tested simultaneously to confirm seroconversion. [11] [12] [13] Seroconversion of IgG in paired samples is considered a strong evidence of infection by M. pneumoniae. 6 Of the serological methods available, the complement fixation test has long been considered the "gold standard," but it is laborious and cumbersome, and it is currently in disuse because it also lacks optimal sensitivity and specificity. 14, 15 In addition, the microagglutination, a more recent method that uses latex particles to avoid non- Monotest, Vircell S.L.) following the instructions of the manufacturer. 18 All assays were performed and analyzed by the same person To evaluate the results found with a single sampling in the acute phase, ROC curves of the antibodies IgG and IgM indices were drawn, and the best cutoff point was compared with the provided by the manufacturer using the kappa index.
| MATERIAL S AND ME THODS
We used Student's t test for the population means with different variances to take into account the age differences of the patients who presented IgM seroconversion.
| RE SULTS
We analyzed paired samples from a total of 137 outpatients with TA 
| D ISCUSS I ON
According to our results, the study of 2 paired serological samples Our study has a number of weaknesses and strengths. We used serological diagnosis as gold standard instead of molecular techniques. Serological testing may be susceptible to immunity status and has to face the difficulty in obtaining convalescent serum which is the main limitation of these techniques. 20 However, our study succeeded in including a high number of patients with paired serum samples with a well-defined pneumonia diagnosis within the context of prospective study of outpatients with CAP. This is a difficult task not achieved by most studies of this type. 11, 16, 21 The nucleic acid amplification techniques are considered more sensitive and reliable than serology, and several multiplex PCR kits allowing the detection of M. pneumoniae along with other respiratory pathogens have been developed. 22 We acknowledged that the use of molecular techniques might have improved the diagnosis sensitivity of serology and allowed the diagnosis of other copathogens in our study. On the other hand, molecular diagnosis is limited by false-positive results from previous infection or the nonpathogenic carrier state 23, 24 and requires respiratory samples suited to nucleic acid amplification, 
| CON CLUS ION
The accuracy of the Virclia ® system by an indirect chemiolumines- 
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